Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis

Abstract Background Fibrotic liver injury is a progressive scarring event, which may permanently affect liver function and progress into devastating end-stage liver diseases due to the absence of effective therapies. Si-Wu-Tang (SWT), a traditional Chinese medicine formula used in clinic to treat gy...

Full description

Bibliographic Details
Main Authors: Xiaoyong Xue, Jianzhi Wu, Mingning Ding, Feng Gao, Fei Zhou, Bing Xu, Mingjun Lu, Jun Li, Xiaojiaoyang Li
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Chinese Medicine
Subjects:
Online Access:https://doi.org/10.1186/s13020-021-00524-0
_version_ 1818858671456649216
author Xiaoyong Xue
Jianzhi Wu
Mingning Ding
Feng Gao
Fei Zhou
Bing Xu
Mingjun Lu
Jun Li
Xiaojiaoyang Li
author_facet Xiaoyong Xue
Jianzhi Wu
Mingning Ding
Feng Gao
Fei Zhou
Bing Xu
Mingjun Lu
Jun Li
Xiaojiaoyang Li
author_sort Xiaoyong Xue
collection DOAJ
description Abstract Background Fibrotic liver injury is a progressive scarring event, which may permanently affect liver function and progress into devastating end-stage liver diseases due to the absence of effective therapies. Si-Wu-Tang (SWT), a traditional Chinese medicine formula used in clinic to treat gynecological disorders for centuries, has been investigated in recent preliminary findings for its role in alleviating chronic liver diseases. Here we aim to elucidate the therapeutic effects and possible mechanisms of SWT against fibrotic liver injury. Methods UHPLC-MS/MS was performed to investigate the chemical characterization of SWT. After intragastrically administered with carbon tetrachloride (CCl4) every 3 days for 1-week, C57BL/6 mice were orally administered with SWT (5.2, 10.4 and 20.8 g/kg) once daily for 3 weeks along with CCl4 challenge. Liver function was determined by the measurement of serum biomarkers, hematoxylin and eosin (H&E) and Masson’s trichrome staining. Intestinal inflammatory infiltration and the disruption of intestinal barrier were examined by H&E and E-cadherin immunohistochemical staining. The microbial composition of intestinal content was determined by 16S rRNA sequencing. Serum bile acids (BAs) profiling was analyzed by LC–MS/MS. Simultaneously, the expression of genes of interest was determined by qPCR and western blot. Results SWT exhibited remarkable therapeutic effects on CCl4-induced liver fibrosis, as indicated by improved collagen accumulation in livers, intestinal barrier injury and hepatic and intestinal inflammatory response. Results of 16S rRNA sequencing revealed that SWT treatment strikingly restructured intestinal microbiota in fibrotic mice by increasing the relative abundances of Bacteroides and Lachnoclostridium and decreasing the relative abundances of Alistipes and Rikenellaceae. UHPLC-MS/MS data suggested that SWT altered the composition of BAs in circulation as evidenced by increased unconjugated BAs like cholic acid and chenodeoxycholic acid but decreased conjugated BAs including taurocholic acid and taurodeoxycholic acid, compared to that in CCl4 mice. Notably, SWT efficiently improved the imbalance of BA homeostasis in livers caused by CCl4 via activating farnesoid X receptor (FXR)-fibroblast growth factor 15 enterohepatic and FXR-small heterodimer partner hepatic pathways. Conclusion SWT decreased inflammatory response, reconstructed gut microbiota-mediated BA homeostasis as well as activated FXR pathways, which eventually protected against CCl4-induced fibrotic liver injury.
first_indexed 2024-12-19T09:00:00Z
format Article
id doaj.art-ac73c5cda094403e9db77b88a0c2c8fb
institution Directory Open Access Journal
issn 1749-8546
language English
last_indexed 2024-12-19T09:00:00Z
publishDate 2021-11-01
publisher BMC
record_format Article
series Chinese Medicine
spelling doaj.art-ac73c5cda094403e9db77b88a0c2c8fb2022-12-21T20:28:30ZengBMCChinese Medicine1749-85462021-11-0116112010.1186/s13020-021-00524-0Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasisXiaoyong Xue0Jianzhi Wu1Mingning Ding2Feng Gao3Fei Zhou4Bing Xu5Mingjun Lu6Jun Li7Xiaojiaoyang Li8School of Life Sciences, Beijing University of Chinese MedicineSchool of Life Sciences, Beijing University of Chinese MedicineSchool of Life Sciences, Beijing University of Chinese MedicineSchool of Chinese Materia Medica, Beijing University of Chinese MedicineSchool of Life Sciences, Beijing University of Chinese MedicineSchool of Chinese Materia Medica, Beijing University of Chinese MedicineSchool of Chinese Materia Medica, Beijing University of Chinese MedicineGynecology Department, Dongzhimen Hospital, Beijing University of Chinese MedicineSchool of Life Sciences, Beijing University of Chinese MedicineAbstract Background Fibrotic liver injury is a progressive scarring event, which may permanently affect liver function and progress into devastating end-stage liver diseases due to the absence of effective therapies. Si-Wu-Tang (SWT), a traditional Chinese medicine formula used in clinic to treat gynecological disorders for centuries, has been investigated in recent preliminary findings for its role in alleviating chronic liver diseases. Here we aim to elucidate the therapeutic effects and possible mechanisms of SWT against fibrotic liver injury. Methods UHPLC-MS/MS was performed to investigate the chemical characterization of SWT. After intragastrically administered with carbon tetrachloride (CCl4) every 3 days for 1-week, C57BL/6 mice were orally administered with SWT (5.2, 10.4 and 20.8 g/kg) once daily for 3 weeks along with CCl4 challenge. Liver function was determined by the measurement of serum biomarkers, hematoxylin and eosin (H&E) and Masson’s trichrome staining. Intestinal inflammatory infiltration and the disruption of intestinal barrier were examined by H&E and E-cadherin immunohistochemical staining. The microbial composition of intestinal content was determined by 16S rRNA sequencing. Serum bile acids (BAs) profiling was analyzed by LC–MS/MS. Simultaneously, the expression of genes of interest was determined by qPCR and western blot. Results SWT exhibited remarkable therapeutic effects on CCl4-induced liver fibrosis, as indicated by improved collagen accumulation in livers, intestinal barrier injury and hepatic and intestinal inflammatory response. Results of 16S rRNA sequencing revealed that SWT treatment strikingly restructured intestinal microbiota in fibrotic mice by increasing the relative abundances of Bacteroides and Lachnoclostridium and decreasing the relative abundances of Alistipes and Rikenellaceae. UHPLC-MS/MS data suggested that SWT altered the composition of BAs in circulation as evidenced by increased unconjugated BAs like cholic acid and chenodeoxycholic acid but decreased conjugated BAs including taurocholic acid and taurodeoxycholic acid, compared to that in CCl4 mice. Notably, SWT efficiently improved the imbalance of BA homeostasis in livers caused by CCl4 via activating farnesoid X receptor (FXR)-fibroblast growth factor 15 enterohepatic and FXR-small heterodimer partner hepatic pathways. Conclusion SWT decreased inflammatory response, reconstructed gut microbiota-mediated BA homeostasis as well as activated FXR pathways, which eventually protected against CCl4-induced fibrotic liver injury.https://doi.org/10.1186/s13020-021-00524-0Si-Wu-TangFibrotic liver injuryBile acidFarnesoid X receptorIntestinal microbiota
spellingShingle Xiaoyong Xue
Jianzhi Wu
Mingning Ding
Feng Gao
Fei Zhou
Bing Xu
Mingjun Lu
Jun Li
Xiaojiaoyang Li
Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
Chinese Medicine
Si-Wu-Tang
Fibrotic liver injury
Bile acid
Farnesoid X receptor
Intestinal microbiota
title Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
title_full Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
title_fullStr Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
title_full_unstemmed Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
title_short Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
title_sort si wu tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
topic Si-Wu-Tang
Fibrotic liver injury
Bile acid
Farnesoid X receptor
Intestinal microbiota
url https://doi.org/10.1186/s13020-021-00524-0
work_keys_str_mv AT xiaoyongxue siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT jianzhiwu siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT mingningding siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT fenggao siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT feizhou siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT bingxu siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT mingjunlu siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT junli siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis
AT xiaojiaoyangli siwutangamelioratesfibroticliverinjuryviamodulatingintestinalmicrobiotaandbileacidhomeostasis